Justin Juang

Justin Juang is currently working as a Research Associate at NewLimit, where Justin focuses on genetically modifying strategies to develop a next-generation tumor-infiltrating lymphocyte (TIL) product. Justin's previous roles include working as a Research Associate at Lyell Immunopharma, an Antibody Discovery Intern at Berkeley Lights, and a Research Associate Intern at RevMAb Biosciences USA, Inc. Justin has a Bachelor of Science in Biomolecular Engineering from the University of California, Santa Cruz. During their time as a Research Intern at UNSW, Justin collected lab data, compared cell micropatterning techniques, and collaborated with scientists in a diverse research environment.